SSX8 anticorps (AA 21-120) (Biotin)
Aperçu rapide pour SSX8 anticorps (AA 21-120) (Biotin) (ABIN760603)
Antigène
Reactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 21-120
-
Réactivité croisée
- Souris
-
Homologie
- Human
-
Purification
- Purified by Protein A.
-
Immunogène
- KLH conjugated synthetic peptide derived from human SSX8
-
Isotype
- IgG
-
-
-
-
Indications d'application
-
WB 1:300-5000
IHC-P 1:200-400
IHC-F 1:100-500 -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 μg/μL
-
Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
-
Agent conservateur
- ProClin
-
Précaution d'utilisation
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- Store at -20°C for 12 months.
-
Date de péremption
- 12 months
-
-
- SSX8 (Synovial Sarcoma, X Breakpoint 8 (SSX8))
-
Autre désignation
- SSX8
-
Sujet
-
Synonyms: Protein SSX8, SSX 8, SSX-8, Synovial sarcoma X breakpoint 8, SSX8_HUMAN.
Background: SSX8 belongs to the family of highly homologous synovial sarcoma X (SSX) breakpoint proteins. These proteins may function as transcriptional repressors. They are also capable of eliciting spontaneously humoral and cellular immune responses in cancer patients, and are potentially useful targets in cancer vaccine-based immunotherapy. SSX1, SSX2 and SSX4 genes have been involved in the t(X,18) translocation characteristically found in all synovial sarcomas.
Antigène
-